Cargando…

Topical treatments for Kaposi sarcoma: A systematic review

BACKGROUND: While treatment options exist for solitary or disseminated Kaposi sarcoma (KS) disease, there are currently no standardized clinical treatment guidelines for cutaneous KS. OBJECTIVE: This systematic review seeks to identify safe and effective topical treatments for cutaneous KS lesions....

Descripción completa

Detalles Bibliográficos
Autores principales: Htet, Kyaw Zin, Waul, Michael Andrew, Leslie, Kieron Seymour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168015/
https://www.ncbi.nlm.nih.gov/pubmed/35677916
http://dx.doi.org/10.1002/ski2.107
_version_ 1784720906268966912
author Htet, Kyaw Zin
Waul, Michael Andrew
Leslie, Kieron Seymour
author_facet Htet, Kyaw Zin
Waul, Michael Andrew
Leslie, Kieron Seymour
author_sort Htet, Kyaw Zin
collection PubMed
description BACKGROUND: While treatment options exist for solitary or disseminated Kaposi sarcoma (KS) disease, there are currently no standardized clinical treatment guidelines for cutaneous KS. OBJECTIVE: This systematic review seeks to identify safe and effective topical treatments for cutaneous KS lesions. METHODS: We conducted a systematic review using peer‐reviewed articles from January 1970 to September 2021 published in the PubMed/MEDLINE and EMBASE databases. RESULTS: From the initial search that yielded 590 studies, 34 met the inclusion criteria and were selected. Of the 34 studies, seven were clinical trials, 26 were case reports/series and one was a multicentre study. A total of 634 patients were included in our review. The three most common topical treatments used for cutaneous KS were imiquimod, alitretinoin and timolol. Topical alitretinoin was used in three case reports and three clinical trials. Topical imiquimod was used in eight case reports, one prospective phase II cohort study and one comparative single‐blinded non‐controlled clinical study. Topical timolol was used in nine case reports/series. Our review also identified reports of less widely used topical treatments for cutaneous KS. These include topical diphencyprone (DPCP), all‐trans‐retinoic‐acid, rapamycin and bleomycin‐dimethylsulfoxide (BLM‐DMSO) which achieved variable response rates but have not been widely studied. CONCLUSION: Topical alitretinoin, imiquimod and timolol demonstrated positive responses for cutaneous KS and the treatments were well tolerated. These three topical treatment modalities could be considered by clinicians when treating cutaneous KS.
format Online
Article
Text
id pubmed-9168015
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91680152022-06-07 Topical treatments for Kaposi sarcoma: A systematic review Htet, Kyaw Zin Waul, Michael Andrew Leslie, Kieron Seymour Skin Health Dis Systematic Review BACKGROUND: While treatment options exist for solitary or disseminated Kaposi sarcoma (KS) disease, there are currently no standardized clinical treatment guidelines for cutaneous KS. OBJECTIVE: This systematic review seeks to identify safe and effective topical treatments for cutaneous KS lesions. METHODS: We conducted a systematic review using peer‐reviewed articles from January 1970 to September 2021 published in the PubMed/MEDLINE and EMBASE databases. RESULTS: From the initial search that yielded 590 studies, 34 met the inclusion criteria and were selected. Of the 34 studies, seven were clinical trials, 26 were case reports/series and one was a multicentre study. A total of 634 patients were included in our review. The three most common topical treatments used for cutaneous KS were imiquimod, alitretinoin and timolol. Topical alitretinoin was used in three case reports and three clinical trials. Topical imiquimod was used in eight case reports, one prospective phase II cohort study and one comparative single‐blinded non‐controlled clinical study. Topical timolol was used in nine case reports/series. Our review also identified reports of less widely used topical treatments for cutaneous KS. These include topical diphencyprone (DPCP), all‐trans‐retinoic‐acid, rapamycin and bleomycin‐dimethylsulfoxide (BLM‐DMSO) which achieved variable response rates but have not been widely studied. CONCLUSION: Topical alitretinoin, imiquimod and timolol demonstrated positive responses for cutaneous KS and the treatments were well tolerated. These three topical treatment modalities could be considered by clinicians when treating cutaneous KS. John Wiley and Sons Inc. 2022-04-08 /pmc/articles/PMC9168015/ /pubmed/35677916 http://dx.doi.org/10.1002/ski2.107 Text en © 2022 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Systematic Review
Htet, Kyaw Zin
Waul, Michael Andrew
Leslie, Kieron Seymour
Topical treatments for Kaposi sarcoma: A systematic review
title Topical treatments for Kaposi sarcoma: A systematic review
title_full Topical treatments for Kaposi sarcoma: A systematic review
title_fullStr Topical treatments for Kaposi sarcoma: A systematic review
title_full_unstemmed Topical treatments for Kaposi sarcoma: A systematic review
title_short Topical treatments for Kaposi sarcoma: A systematic review
title_sort topical treatments for kaposi sarcoma: a systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168015/
https://www.ncbi.nlm.nih.gov/pubmed/35677916
http://dx.doi.org/10.1002/ski2.107
work_keys_str_mv AT htetkyawzin topicaltreatmentsforkaposisarcomaasystematicreview
AT waulmichaelandrew topicaltreatmentsforkaposisarcomaasystematicreview
AT lesliekieronseymour topicaltreatmentsforkaposisarcomaasystematicreview